Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Medical Genetics

The Biology of BBS: Cellular Antennas and Genetics

At a Glance

Bardet-Biedl Syndrome (BBS) is caused by mutations affecting the primary cilium, a cellular antenna that processes vital signals. Inherited as an autosomal recessive condition, BBS impacts multiple organs. Genetic testing identifies specific gene mutations to guide treatments and monitor risks.

To understand why Bardet-Biedl Syndrome (BBS) affects so many different parts of the body—from the eyes to the kidneys to how the body stores fat—it is necessary to look at the very foundation of your cells.

The Cellular “Antenna” Problem

Nearly every cell in the human body has a single, hair-like structure on its surface called a primary cilium [1]. You can think of this cilium as a “cellular antenna.” Its job is to receive signals from outside the cell and pass them inside so the cell knows how to behave [2].

In BBS, the problem lies in a group of proteins known as the BBSome [3]. The BBSome acts like a delivery truck, moving “cargo” (signaling receptors) in and out of the antenna [4][5]. When the BBSome is broken due to a genetic mutation:

  • Signals get stuck: Important receptors like the ones for insulin or appetite regulation cannot move correctly, leading to issues like obesity [6][7].
  • Signals are missed: The eyes cannot properly process light signals, leading to vision loss [8].
  • Systems malfunction: Because these antennas are found in almost every organ, their failure causes the wide-ranging “multisystem” symptoms of BBS [8][1].

How BBS is Inherited

BBS is typically an autosomal recessive condition [9]. This means that for a person to have the syndrome, they must inherit two changed (mutated) copies of a BBS gene—one from their mother and one from their father.

  • The Carrier State: Most parents of a child with BBS are “carriers.” They have one working copy of the gene and one mutated copy. Carriers usually have no symptoms of the syndrome because their working copy is enough to keep their cellular antennas functioning [10].
  • The Risk: When two carriers have a child, there is a 25% (1 in 4) chance with each pregnancy that the child will inherit both mutated copies and have BBS. There is a 50% chance the child will be a carrier like the parents, and a 25% chance they will inherit two working copies [9][10].

The Role of Specific Genes

There are at least 26 different genes that can cause BBS [11]. Knowing which gene is affected can sometimes help doctors predict what to expect:

  • BBS1: This is one of the most common genes. It is often associated with a “milder” course, meaning patients may have a lower risk of severe kidney disease compared to other types [12][13].
  • BBS10 and BBS2: These are also very common but are sometimes linked to more severe symptoms across the body, including a higher risk of kidney issues [12][13].
  • Truncating Variants: If a genetic test shows a “truncating” mutation (where the protein is cut short), there may be an increased risk for kidney failure [14].

Why Genetic Testing is Critical

While doctors can often suspect BBS based on symptoms, Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS) is now the gold standard for confirmation [15][16]. These tests look at all of a person’s genes at once.

Genetic testing is not just about a name for the condition; it is a tool for:

  1. Precision Care: Identifying the exact gene helps doctors monitor specific risks, like kidney function, more closely [17][1].
  2. Access to Treatments: Some newer medications or clinical trials require genetic proof of the diagnosis [11][18].
  3. Family Planning: Knowing the exact mutations allows patients to test future pregnancies or help siblings understand their own carrier status [10].
  4. Ending the Search: Rapid genetic testing can cut years off the “diagnostic odyssey,” saving families from unnecessary tests and uncertainty [19].

Common questions in this guide

How is Bardet-Biedl Syndrome inherited?
BBS is usually an autosomal recessive condition. This means a child must inherit two mutated copies of a BBS gene, one from each parent, to develop the syndrome. Parents who carry only one mutated copy typically do not have symptoms.
What is the BBSome and how does it affect my cells?
The BBSome acts like a delivery truck that moves signals in and out of a cell's primary cilium, which functions as an antenna. When the BBSome is broken due to a genetic mutation, cells cannot process signals correctly, leading to BBS symptoms.
Does it matter which specific BBS gene is mutated?
Yes, the specific gene involved can help predict the severity of symptoms. For example, BBS1 mutations are often associated with milder symptoms, while BBS10 or BBS2 mutations may indicate a higher risk for severe kidney issues.
Why is genetic testing important for Bardet-Biedl Syndrome?
Genetic testing confirms the exact BBS diagnosis and helps doctors provide precision care. It can guide specific medical monitoring for your organs, determine eligibility for new treatments or clinical trials, and assist with family planning.
What happens if my genetic test shows a truncating variant?
A truncating variant means the affected protein is cut short and cannot function properly. In BBS, having a truncating mutation may indicate an increased risk for kidney failure, which means your doctor will likely monitor your kidney function more closely.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific BBS gene was identified in my results, and is the mutation considered 'truncating' or 'missense'?
  2. 2.Does my specific genetic variant (e.g., BBS1 vs. BBS10) suggest a higher or lower risk for early-onset kidney disease?
  3. 3.Should we use Whole Genome Sequencing (WGS) if my initial panel or exome testing was negative but symptoms strongly suggest BBS?
  4. 4.What are the specific risks for my future children, and what testing or counseling options are available for family planning?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do.

    Caba L, Florea L, Braha EE, et al.

    Journal of multidisciplinary healthcare 2022; (15()):2153-2167 doi:10.2147/JMDH.S274739.

    PMID: 36193191
  2. 2

    BBS8-dependent ciliary Hedgehog signaling governs cell fate in the white adipose tissue.

    Sieckmann K, Winnerling N, Silva Ribeiro DJ, et al.

    The EMBO journal 2025; (44(19)):5315-5336 doi:10.1038/s44318-025-00524-y.

    PMID: 40836034
  3. 3

    ARL3 mediates BBSome ciliary turnover by promoting its outward movement across the transition zone.

    Liu YX, Sun WY, Xue B, et al.

    The Journal of cell biology 2022; (221(10)) doi:10.1083/jcb.202111076.

    PMID: 36129685
  4. 4

    BBS1 is involved in retrograde trafficking of ciliary GPCRs in the context of the BBSome complex.

    Nozaki S, Katoh Y, Kobayashi T, Nakayama K

    PloS one 2018; (13(3)):e0195005 doi:10.1371/journal.pone.0195005.

    PMID: 29590217
  5. 5

    Intraflagellar transport protein RABL5/IFT22 recruits the BBSome to the basal body through the GTPase ARL6/BBS3.

    Xue B, Liu YX, Dong B, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2020; (117(5)):2496-2505 doi:10.1073/pnas.1901665117.

    PMID: 31953262
  6. 6

    CEP19-RABL2-IFT-B axis controls BBSome-mediated ciliary GPCR export.

    Zhou Z, Katoh Y, Nakayama K

    Molecular biology of the cell 2022; (33(13)):ar126 doi:10.1091/mbc.E22-05-0161.

    PMID: 36074075
  7. 7

    Loss of the Bardet-Biedl protein Bbs1 alters photoreceptor outer segment protein and lipid composition.

    Masek M, Etard C, Hofmann C, et al.

    Nature communications 2022; (13(1)):1282 doi:10.1038/s41467-022-28982-6.

    PMID: 35277505
  8. 8

    Ciliary signaling proteins are mislocalized in the brains of Bardet-Biedl syndrome 1-null mice.

    Stubbs T, Bingman JI, Besse J, Mykytyn K

    Frontiers in cell and developmental biology 2022; (10()):1092161 doi:10.3389/fcell.2022.1092161.

    PMID: 36699005
  9. 9

    Characterizing the morbid genome of ciliopathies.

    Shaheen R, Szymanska K, Basu B, et al.

    Genome biology 2016; (17(1)):242 doi:10.1186/s13059-016-1099-5.

    PMID: 27894351
  10. 10

    Delayed identification of Bardet-Biedl syndrome.

    Kanitkar S, Ande SP, Shivnitwar SK, Edara M

    BMJ case reports 2024; (17(11)) doi:10.1136/bcr-2024-261843.

    PMID: 39542505
  11. 11

    Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations.

    Dollfus H, Lilien MR, Maffei P, et al.

    European journal of human genetics : EJHG 2024; (32(11)):1347-1360 doi:10.1038/s41431-024-01634-7.

    PMID: 39085583
  12. 12

    Exploring Key Challenges of Understanding the Pathogenesis of Kidney Disease in Bardet-Biedl Syndrome.

    Marchese E, Ruoppolo M, Perna A, et al.

    Kidney international reports 2020; (5(9)):1403-1415 doi:10.1016/j.ekir.2020.06.017.

    PMID: 32954066
  13. 13

    A Genotype-Phenotype Analysis of the Bardet-Biedl Syndrome in Puerto Rico.

    Guardiola GA, Ramos F, Izquierdo NJ, Oliver AL

    Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):3757-3764 doi:10.2147/OPTH.S328493.

    PMID: 34526762
  14. 14

    Kidney failure in Bardet-Biedl syndrome.

    Meyer JR, Krentz AD, Berg RL, et al.

    Clinical genetics 2022; (101(4)):429-441 doi:10.1111/cge.14119.

    PMID: 35112343
  15. 15

    How exome sequencing improves the diagnostics and management of men with non-syndromic infertility.

    Stallmeyer B, Dicke AK, Tüttelmann F

    Andrology 2025; (13(5)):1011-1024 doi:10.1111/andr.13728.

    PMID: 39120565
  16. 16

    Whole-genome sequencing in clinically diagnosed Charcot-Marie-Tooth disease undiagnosed by whole-exome sequencing.

    Kim YG, Kwon H, Park JH, et al.

    Brain communications 2023; (5(3)):fcad139 doi:10.1093/braincomms/fcad139.

    PMID: 37180992
  17. 17

    CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology.

    Zacchia M, Secondulfo F, Melluso A, et al.

    Kidney international reports 2025; (10(2)):375-385 doi:10.1016/j.ekir.2024.10.030.

    PMID: 39990901
  18. 18

    Bardet-Biedl Syndrome in Four Siblings: Clinical and Genetic Insights From a Rare Familial Cluster.

    Jena D, Pattanaik S, Sahoo SK, et al.

    AACE endocrinology and diabetes 2026; (13(1)):22-26 doi:10.1016/j.aed.2025.08.019.

    PMID: 41641302
  19. 19

    Better and faster is cheaper.

    Sanford Kobayashi EF, Dimmock DP

    Human mutation 2022; (43(11)):1495-1506 doi:10.1002/humu.24422.

    PMID: 35723630

This page explains the biology and genetics of Bardet-Biedl Syndrome for educational purposes. Always consult a genetic counselor or healthcare provider to interpret your specific genetic test results.

Get notified when new evidence is published on Bardet-Biedl syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.